11/18/2025
💊 Specialty Drug Costs Are Reshaping Rheumatology — Here’s How Practices Can Stay Ahead
Rheumatology practices face some of the most significant financial pressures in healthcare today. Specialty drugs now make up 50% of all prescription spending, and Medicare spending on these medications has surged over 566.5% in the last decade.
To remain sustainable, independent practices need stronger strategies for managing drug costs, inventory, and reimbursement complexity.
Inside our latest blog, we explore how rheumatology-focused purchasing programs help practices:
✔️ Lower acquisition costs on high-cost biologics
✔️ Improve cash flow through smarter inventory management
✔️ Reduce administrative burden and vendor complexity
✔️ Ensure reliable access to critical therapies
✔️ Strengthen performance in value-based care models
✔️ Gain data-driven insights that improve financial and operational decision-making
At Articularis Healthcare Group, we specialize in drug purchasing and management programs built specifically for rheumatology — empowering practices to stay independent, financially strong, and focused on patient care.
🔗 Read the full article: https://articularishealthcare.com/news/the-benefits-of-drug-purchasing-and-management-programs-for-rheumatology-practices/
